BAY 60-7550
![]() | |
Names | |
---|---|
Preferred IUPAC name
2-[(3,4-Dimethoxyphenyl)methyl]-7-[(2R,3R)-2-hydroxy-6-phenylhexan-3-yl]-5-methylimidazo[5,1-f][1,2,4]triazin-4(1H)-one | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C27H32N4O4 | |
Molar mass | 476.577 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
BAY 60-7550 is a type 2 phosphodiesterase inhibitor.[1]
References[]
- ^ Van Donkelaar, EL; Prickaerts, J; Akkerman, S; Rutten, K; Steinbusch, HW; Blokland, A (2013). "No effect of acute tryptophan depletion on phosphodiesterase inhibition--related improvements of short-term object memory in male Wistar rats". Acta Psychiatrica Scandinavica. 128 (2): 107–13. doi:10.1111/acps.12166. PMID 23772681. S2CID 19169985.
Categories:
- Phosphodiesterase inhibitors
- Organic compound stubs